第一单位：
1Department of Dermatology and Allergy, Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany.
作者：
M,Maurer [1]
;
K,Houghton [2]
;
C,Costa [3]
;
F,Dabove [4]
;
L F,Ensina [5]
;
A,Giménez-Arnau [6]
;
G,Guillet [7]
;
G N,Konstantinou [8]
;
M,Labrador-Horrillo [9]
;
H,Lapeere [10]
;
R,Meshkova [11]
;
E A,Pastorello [12]
;
M,Velásquez-Lopera [13]
;
L M,Tamayo Quijano [14]
;
C,Vestergaard [15]
;
N,Chapman-Rothe [16]
作者单位：
1Department of Dermatology and Allergy, Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany.
[1]
RTI Health Solutions, Carolina, North, USA.
[2]
3Serviço de Imunoalergologia, Hospital de Santa Maria, Lisbon, Portugal.
[3]
Center of Medical Specialties Lobos, Buenos Aires, Argentina.
[4]
CPAlpha Clinical Research Center, São Paulo, Brazil.;6Hospital Sírio-Libanês, São Paulo, Brazil.
[5]
7Hospital del Mar, Parc de Salut Mar, IMIM, Universitat Autònoma de Barcelona, Barcelona, Spain.
[6]
8Service de Dermato-allergologie, CHU Poitiers, Poitiers, France.
[7]
Department of Allergy and Clinical Immunology, 424 General Military Training Hospital, Thessaloniki, Greece.
[8]
10Hospital Vall d'Hebron, VHIR, Universitat Autònoma de Barcelona, Barcelona, Spain.
[9]
11Department of Dermatology, Ghent University Hospital, Ghent, Belgium.
[10]
12Allergy and Clinical Immunology, Smolensk State Medical University, Smolensk, Russia.
[11]
S.C. di Allergologia e Immunologia ASST Grande Ospedale Metropolitano Niguarda Milan, Milan, Italy.
[12]
14Centro de Investigaciones Dermatológicas, CIDERM, University of Antioquia, Medellín, Colombia.
[13]
15Pontificia Bolivariana University, Medellín, Colombia.
[14]
16Department of Dermatology and Venereology, Aarhus University Hospital, Aarhus, Denmark.
[15]
17Novartis Pharma AG, Basel, Switzerland.
[16]
DOI
10.1186/s40413-018-0216-1
PMID
30464782
发布时间
2022-03-30
换一批
